Named on one round in the feed.
Since 2023-08-23
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
FORE Biotherapeutics A cancer therapeutics company developing targeted treatments for hard-to-treat tumours | Series D+ Verified against 1 source[ HISTORY ]: An earlier round of this company, found through its checked dossier and read from its own announcement like any round. Not news: never sent, and left out of the feed unless you filter by date. | $75M | 2023-08-23 | [ PART ] |